Search clinical trials for: bortezomib (Velcade)
Total 1013 results
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLCWithdrawnMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedAllogeneic Stem Cell Transplantation | Refractory Autoimmune Cytopenia(s)United States
-
Janssen Korea, Ltd., KoreaCompleted
-
Milton S. Hershey Medical CenterUnknownMantle Cell LymphomaUnited States
-
Bristol-Myers SquibbTerminatedMultiple MyelomaUnited States, Italy, France, Spain
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.Completed
-
Zhengang YuanUnknown
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ortho Biotech, Inc.Completed
-
Mayo ClinicNational Cancer Institute (NCI)CompletedLeukemia | Chronic Myeloproliferative DisordersUnited States
-
Baylor College of MedicineMillennium Pharmaceuticals, Inc.CompletedProstate NeoplasmsUnited States
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.Unknown
-
NYU Langone HealthMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple MyelomaUnited States
-
University Hospital, ToulouseCelgene Corporation; Janssen-Cilag Ltd.Completed
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedMultiple MyelomaUnited States, Philippines, United Kingdom
-
Nantes University HospitalCompleted
-
SanofiCompletedMultiple MyelomaFrance, Italy
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Blastic Phase Chronic Myelogenous Leukemia and other conditionsUnited States
-
University of CologneJohnson & Johnson Pharmaceutical Research & Development, L.L.C.; German Hodgkin...Terminated
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
PETHEMA FoundationCompleted
-
OncotherapeuticsCelgene CorporationCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedMultiple MyelomaUnited States
-
University of BolognaCompleted
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
National Cancer Institute (NCI)CompletedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid... and other conditionsUnited States
-
Merck Sharp & Dohme LLCTerminatedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.Completed
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral... and other conditionsUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Boston VA Research Institute, Inc.Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Korean Multiple Myeloma Working PartyJanssen-Cilag Ltd.CompletedMultiple MyelomaKorea, Republic of
-
Intergroupe Francophone du MyelomeCompleted
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminated
-
Ohio State University Comprehensive Cancer CenterCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States
-
Janssen-Cilag International NVTerminatedMultiple MyelomaPoland, Turkey, Russian Federation, Hungary, Lithuania, Croatia, Germany
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
Asan Medical CenterUnknownKidney TransplantationKorea, Republic of
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States